![Michael Gold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Gold
Directeur Technique/Scientifique/R&D chez
COMPASS PATHWAYS PLC
Profil
Michael Gold is currently the Chief Research & Development Officer at Compass Pathways Plc.
Previously, he worked as the Medical Director-Memory Disorder Clinic at the University of South Florida.
From 2017 to 2023, he served as the Vice President at AbbVie, Inc. In 2011 to 2013, he held the position of Chief Medical Officer at Allon Therapeutics, Inc. Additionally, from 2023 to 2024, he was the Chief Medical Officer at Neumora Therapeutics, Inc. Dr. Gold obtained his undergraduate, graduate, and doctorate degrees from the University of Miami.
Postes actifs de Michael Gold
| Sociétés | Poste | Début |
|---|---|---|
| COMPASS PATHWAYS PLC | Directeur Technique/Scientifique/R&D | 01/05/2024 |
Anciens postes connus de Michael Gold
| Sociétés | Poste | Fin |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 29/02/2024 |
| ABBVIE INC. | Corporate Officer/Principal | 01/01/2023 |
| ALLON THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/01/2013 |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Michael Gold
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Allon Therapeutics, Inc.
 Allon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to protect against neurodegenerative conditions | Health Technology |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
